A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Dynagenix in Post-Exercise Musculoskeletal Function Recovery in Healthy Subjects

The clinical study  on Dynagenix is currently not published, but we’d like to provide you with more information on the trial. Please fill out the form on this page and we will contact you.

Study Demonstrates Improved Supports Muscle and Joint Comfort with Enhanced Recovery and Strength After Exercise

The strong anti-inflammatory properties of PLT’s Boswellia serrata-based ingredients have been well-established through more than a decade of peer-reviewed research. Looking to extend the understanding of this ingredient on the human body, PLT’s clinical trial design used a model that would stress both muscles and joints to demonstrate Dynagenix’s efficacy.

In the trial, 50 recreationally active men (age 25-40) were studied for their response to eccentric exercise-related Delayed-Onset Muscle Soreness using 60mg of Dynagenix versus a placebo. The supplementation period was 10 days with eccentric exercise intervention on day 7. Testing occurred at baseline and on days 7-10.